Investor Day & Corporate Videos

 

Investor Day 2013 Presentations – click here for slide presentations

BioTime, Inc. Investor Day 2013 – Keynote Speaker Michael D. West, Ph.D., CEO and President, BioTime, Inc.

BioTime, Inc. Investor Day 2013 – Presentation by William P. Tew, Ph.D., CCO, BioTime, Inc. Renevia™ and HyStem® family of products

BioTime, Inc. Investor Day 2013 – Presentation by Francois Binette, Ph.D., VP Research & Business Development, OrthoCyte Corp.

BioTime, Inc. Investor Day 2013 – Presentation by David Washawsky, Ph.D., President and CEO, LifeMap Sciences, Inc.

BioTime, Inc. Investor Day 2013 – Presentation by Dr Joseph Wagner, CEO, OncoCyte Corp.

BioTime, Inc. Investor Day 2013 – Presentation by Jeffrey Janus, MBA, VP Sales and Marketing, BioTime, Inc. , CEO, ESI-BIO

BioTime, Inc. Investor Day 2013 – Presentation by Charles S. Irving, Ph.D., CEO CellCure NeuroSciences Ltd.

BioTime, Inc. Investor Day 2013 – Presentation by Eric Schadt, Ph.D., Icahn School of Medicine at Mount Sinai.

BioTime, Inc. Investor Day 2013 – Presentation by David Larocca, PhD & Shahin Rafii, M.D.

Corporate Videos

Advantages and Derivation of PureStem Human Embryonic Progenitors

Product Development Update:
Fate Space Screening

Development of HyStem®: Part 1 — Glenn Prestwich, Ph.D.

Development of HyStem®: Parts 2 & 3 — Glenn Prestwich, Ph.D.

Product Development Update:
LifeMap Discovery

Product Development Update: Renevia™

OrthoCyte’s CSO Dr. Arnold Caplan Discusses Product Development

Discussion of Glycosan Acquisition and use of Hydrogels in Tissue Engineering

OrthoCyte’s Chief Scientific Officer Dr. Arnold Caplan – cartilage biology

BioTime 2012 Annual Shareholder Meeting

 BioTime Investor Day 2012 Presentations

Keynote Speaker –
Andrew von Eschenbach, M.D

Introduction to BioTime –
Michael West, Ph.D.

OrthoCyte’s HyStem Family of Products
– William Tew, Ph.D.

CellCure Nerosciences –
Charles Irving, Ph.D.

OncoCyte – Joseph Wagner, Ph.D.
and Karen Chapman, Ph.D.

OrthoCyte
Arnold I. Caplan, Ph.D.

ReCyte Therapeutics – Steven Kessler,
Ph.D and Shahin Rafii, M.D.

LifeMap Sciences –
David Warshawsky, Ph.D.

Overview of BioTime Investment Opportunities – Peter Garcia

Other Videos

The Stem Cell Controversy, Featuring Dr. Michael West